Kiadis Pharma Announces Enrollment Of First Patients In A Multinational Registration Study For ATIR(TM)
AMSTERDAM, November 30 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today that the first patients have been enrolled in its multinational registration clinical trial with ATIR(TM…